Titan Pharmaceuticals
Why Robinhood?
You can watch TTNP and buy or sell other stocks, ETFs, and their options commission-free!About TTNP
Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its lead product is probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction.
TTNP Key Statistics
Stock Snapshot
As of today, Titan Pharmaceuticals(TTNP) shares are valued at $23.98. The company's market cap stands at 33.52M, with a P/E ratio of -1.71.
On 2026-02-03, Titan Pharmaceuticals(TTNP) stock opened at —, reached a high of —, and a low of —.
Titan Pharmaceuticals(TTNP) shares are trading with a volume of 0.
In the last year, Titan Pharmaceuticals(TTNP) shares hit a 52-week high of $5.76 and a 52-week low of $3.20.
In the last year, Titan Pharmaceuticals(TTNP) shares hit a 52-week high of $5.76 and a 52-week low of $3.20.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.